Viewing Study NCT02824003


Ignite Creation Date: 2025-12-24 @ 7:11 PM
Ignite Modification Date: 2026-01-04 @ 5:15 PM
Study NCT ID: NCT02824003
Status: COMPLETED
Last Update Posted: 2018-05-08
First Post: 2016-06-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the Effect of ISIS GCGRRx on Hepatic Lipid and Glycogen Content in Type 2 Diabetes
Sponsor: Ionis Pharmaceuticals, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-04
Start Date Type: ACTUAL
Primary Completion Date: 2016-12-15
Primary Completion Date Type: ACTUAL
Completion Date: 2017-05-22
Completion Date Type: ACTUAL
First Submit Date: 2016-06-15
First Submit QC Date: None
Study First Post Date: 2016-07-06
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-05-04
Last Update Post Date: 2018-05-08
Last Update Post Date Type: ACTUAL